COCP 8-K 2026-08-17

Cocrystal Pharma, Inc. (COCP) 8-K dated 2026-08-17 — accession 0001493152-26-038747. This URL is the filing, not the COCP hub.

Cocrystal Pharma, Inc. (COCP) is a biotechnology company listed on US.

Cocrystal Pharma, Inc. filed a 8-K on 2026-08-17. Accession 0001493152-26-038747.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.

Not investment advice. The COCP SEC hub lists recent forms. The stock page is the research view.